Adults taking part in a Swiss pilot allowing pharmacies to sell recreational cannabis reported small improvements in mental health, with the largest reduction in problematic use among those at highest risk. This story first appeared on leafie, view here Author: Liam O'Dowd
Endometriosis affects an estimated 190 million people worldwide, and gaps in care are leading to an increased interest in cannabis-based medicines. What do we know about how these might help, and does the science support it? Go to Source Author:
Copeia co-founder Garvin Hirt will join researchers in Frankfurt to discuss how politicians and doctors should make cannabis decisions when evidence is incomplete. Go to Source Author:
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.